Corium, Inc. recently announced a collaboration agreement with Covestro LLC to develop materials for advanced drug delivery systems.
The agreement brings together Corium`s expertise in transdermal drug delivery with Covestro`s knowledge of thermoplastic polyurethane (TPU) materials, which are used in a variety of medical device applications.
Under the agreement, the two companies will work together to develop new TPU-based formulations that can be used in Corium`s transdermal drug delivery systems. The goal is to create materials that offer greater flexibility, durability, and adhesion than existing formulations, while also maintaining high levels of drug delivery efficiency.
Transdermal drug delivery systems have become increasingly popular in recent years, as they offer a convenient and painless way to administer medications. By applying a patch to the skin, the drug can be delivered directly into the bloodstream, bypassing the digestive system and avoiding the potential side effects that come with oral medication.
However, developing effective transdermal drug delivery systems requires a deep understanding of both the pharmacology of the drug and the properties of the materials used in the delivery system. That`s where the collaboration between Corium and Covestro comes in.
Covestro is a leading provider of TPU materials, which offer a number of advantages for medical device applications. These materials are highly durable, resistant to wear and tear, and provide excellent adhesion to a variety of surfaces. They are also biocompatible, meaning that they can be safely used in the body without causing adverse reactions.
With the help of Covestro`s TPU expertise, Corium hopes to develop new transdermal drug delivery systems that are more reliable, comfortable, and effective. The company`s existing portfolio includes a range of products designed to treat conditions such as migraines, Parkinson`s disease, Alzheimer`s disease, and osteoporosis.
The collaboration between Corium and Covestro is just one example of the growing interest in advanced drug delivery systems. As healthcare providers seek out new ways to deliver medications safely and effectively, the role of materials science in this field will continue to expand.
For anyone interested in the latest developments in transdermal drug delivery, the Corium-Covestro agreement is certainly worth watching. By combining the strengths of these two companies, we may see the emergence of innovative new drug delivery systems that could transform the way we think about medication.